Prospective randomized multicenter phase IIi study of treatment of hormone refractory prostatic cancer: mitomycin C vs. 4-epirubicin vs. estramustine phosphate
Weissbach, L.
Der Urologe. Ausg. a 31(1): 62
1992
ISSN/ISBN: 0340-2592 PMID: 1553805 Document Number: 391248
Document emailed within 1 workday
Related Documents
Sinibaldi, V.J.; Carducci, M.; Laufer, M.; Eisenberger, M. 1999: Preliminary evaluation of a short course of estramustine phosphate and docetaxel (Taxotere) in the treatment of hormone-refractory prostate cancer Seminars in Oncology 26(5 Suppl 17: 45-48Awakura, Y.; Yamamoto, M.; Fukuzawa, S.; Itoh, N.; Nonomura, M.; Fukuyama, T. 2000: Clinical evaluation of estramustine phosphate and vinblastine in patients with hormone-refractory prostate cancer Hinyokika Kiyo. Acta Urologica Japonica 46(7): 449-452
Burk, K.; Schultze-Seemann, W.; Jonas, D.; Rodeck, G. 1989: Weekly epirubicin in patients with hormone refractory prostatic cancer--a two-year follow-up Progress in Clinical and Biological Research 303: 277-285
Van Poppel, H.; Werbrouck, P.W.; Baert, L. 1990: Effect of estramustine phosphate on free androgens. a comparative study of the effect of orchiectomy and estramustine phosphate on free androgens in patients with prostatic cancer Acta Urologica Belgica 58(4): 89-95
Coccaro, M.; Tartarone, A.; Romano, G.; Ardito, R.; Di Renzo, N. 2005: Dose-finding study of weekly docetaxel plus estramustine in patients with hormone-refractory metastatic prostate cancer Tumori 91(4): 314-316
Nishio, S.; Kishimoto, T.; Maekawa, M.; Kawakita, J.; Hayahara, N.; Yuki, K.; Morikawa, Y.; Yasumoto, R.; Kato, Y.; Funai, K. 1986: Clinical effects of estramustine phosphate disodium (Estracyt) on prostatic cancer Hinyokika Kiyo. Acta Urologica Japonica 32(11): 1763-1770
Eichenfield, L.F.; Alió Sáenz, A.B. 2011: Safety and efficacy of clindamycin phosphate 1.2%-benzoyl peroxide 3% fixed-dose combination gel for the treatment of acne vulgaris: a phase 3, multicenter, randomized, double-blind, active- and vehicle-controlled study Journal of Drugs in Dermatology: Jdd 10(12): 1382-1396
Erpenbach, K.; Miller, K. 1992: Prospective randomized multicenter phase IIB study in patients with mumps orchitis Der Urologe. Ausg. a 31(5): 317-318
Takada, T.; Nimura, Y.; Katoh, H.; Nagakawa, T.; Nakayama, T.; Matsushiro, T.; Amano, H.; Wada, K. 1998: Prospective randomized trial of 5-fluorouracil, doxorubicin, and mitomycin C for non-resectable pancreatic and biliary carcinoma: multicenter randomized trial Hepato-Gastroenterology 45(24): 2020-2026
Boehmer, A.; Anastasiadis, A.G.; Feyerabend, S.; Nagele, U.; Kuczyk, M.; Schilling, D.; Corvin, S.; Merseburger, A.S.; Stenzl, A. 2005: Docetaxel, estramustine and prednisone for hormone-refractory prostate cancer: a single-center experience Anticancer Research 25(6c): 4481-4486
Dieras, V.; Marty, M.; Tubiana, N.; Corette, L.; Morvan, F.; Serin, D.; Mignot, L.; Chazard, M.; Garet, F.; Onetto, N. 1995: Phase Ii randomized study of paclitaxel versus mitomycin in advanced breast cancer Seminars in Oncology 22(4 Suppl 8: 33-39
Gustafson, A.; Persson, B.; Tisell, L.E.; Wiklund, O.; Ohlson, R. 1977: Treatment of oral estramustine phosphate (Estracyt) in prostatic carcinoma: influences on lipid and carbohydrate metabolism Investigative Urology 15(3): 220-224
Parente, F.; Bianchi Porro, G.; Canali, A.; Bensi, G. 1995: Double-blind randomized, multicenter study comparing aluminium phosphate gel with rantitidine in the short-term treatment of duodenal ulcer Hepato-Gastroenterology 42(2): 95-99
Lück, H.J.; Thomssen, C.; du Bois, A.; Lisboa, B.W.; Untch, M.; Kühnle, H.; Jänicke, F.; Meerpohl, H.G.; Lindner, C.; Konecny, G.; Hecker, D.; Diergarten, K. 1997: Preliminary results of a phase Ii study of epirubicin and paclitaxel as first-line treatment in patients with metastatic breast cancer Seminars in Oncology 24(1 Suppl 3: S13-S16
Jiang, Z.F.; Xu, F.R.; Fan, J.; Li, B.J.; Gao, J.N.; Hu, J.W.; Wang, X.J.; Zhang, Y.Q.; Wang, J.H.; Li, F.; Liu, Q.; Liu, Y.H.; Wang, S.; Wang, Y.S.; Ouyang, Q.C.; Hu, B.; Sun, G.P.; Zhang, Y.; Zang, A.M.; Fan, P.Z.; Wu, C.P.; Liu, J.; Zhang, H.W.; Wang, W.; Hu, X.C.; Tang, L.L.; Zhang, J.; Bao, Y.Y.; Geng, C.Z.; Sun, Q.; Zhang, F.; Yin, Y.M.; Jiang, H.C.; An, Y.H. 2018: A multicenter, randomized, controlled, phase Ⅳ clinical study of PEG-rhG-CSF for preventing chemotherapy induced neutropenia in patients with breast cancer Zhonghua Yi Xue Za Zhi 98(16): 1231-1235
Stoter, G.; Jones, W.G. 1988: Chemotherapy of hormone refractory prostatic cancer Progress in Clinical and Biological Research 260: 123-125
Tschen, E.H.; Bucko, A.D.; Oizumi, N.; Kawabata, H.; Olin, J.T.; Pillai, R. 2013: Efinaconazole solution in the treatment of toenail onychomycosis: a phase 2, multicenter, randomized, double-blind study Journal of Drugs in Dermatology: Jdd 12(2): 186-192
Knönagel, H.; Bolle, J.F.; Hering, F.; Senn, E.; Hodel, T.; Neuenschwander, H.; Biedermann, C. 1989: Therapy of metastatic prostatic cancer by orchiectomy plus Anandron versus orchiectomy plus placebo. Initial results of a randomized multicenter study Helvetica Chirurgica Acta 56(3): 343-345
Semiglazov, V.F.; Moiseenko, V.M.; Ivanova, O.A. 1986: Prospective randomized study of the efficacy of adjuvant hormone therapy in patients with breast cancer Voprosy Onkologii 32(8): 31-34
Li, N-chen.; Ye, Z-qun.; Na, Y-qun.; Na, Y-qun.; Li, N-chen.; Wei, D.; Xu, K.; Song, Y.; Lu, W-cheng.; Chen, S.; Li, C-ling.; Fan, X-rong.; Jiang, Y-guang.; Tong-wen, O.; Zhang, J.; Kong, C-ze.; Song, X-shuang.; Chen, L-wu.; Huang, J.; Zhang-qun, Y.; Wang, X.; Zhang, W.; Huo, H-xu.; Sun, G.; Wang, Z-ping.; Wei, Q.; Wei, J-xing.; Da-lin, H.; Liu, X-heng.; Zhong, W-de. 2013: Efficacy of immediate instillation combined with regular instillations of pirarubicin for Ta and T1 transitional cell bladder cancer after transurethral resection: a prospective, randomized, multicenter study Chinese Medical Journal 126(15): 2805-2809